Yahoo Web Search

Search results

1. www.baxter.com › baxter-newsroom › baxter-reportsBaxter Reports Fourth-Quarter and Full-Year 2021 Results

   www.baxter.com › baxter-newsroom › baxter-reports

   • Cached

   Feb 17, 2022 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022.

   • Baxter Reports Fourth-Quarter and Full-Year 2022 Results

     The accompanying schedules include additional details on...

2. Images

   • 
   • 
   • 
   • 

   View all

3. www.baxter.com › baxter-newsroom › baxter-reportsBaxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com › baxter-newsroom › baxter-reports

   • Cached

   Feb 9, 2023 · The accompanying schedules include additional details on sales performance by product categories and segments. For full-year 2022, net income (loss) attributable to Baxter totaled ($2.4 billion), or ($4.83) per diluted share on a U.S. GAAP basis.

4. www.businesswire.com › news › homeBaxter Reports First-Quarter 2022 Results - Business Wire

   www.businesswire.com › news › home

   • Cached

   Apr 28, 2022 · Baxter expects full-year 2022 sales growth of 23% to 24% on a reported basis, 25% to 26% on a constant currency basis and approximately 3% on an operational basis. Baxter expects...

5. seekingalpha.com › article › 4487950-baxterBaxter International's (BAX) CEO Joe Almeida on Q4 2021 ...

   seekingalpha.com › article › 4487950-baxter

   Feb 17, 2022 · On the call this morning, we will be discussing Baxter's fourth quarter and full year 2021 financial results along with our financial outlook for 2022.

6. www.baxter.com › baxter-newsroom › baxter-reportsBaxter Reports Fourth-Quarter and Full-Year 2020 Results

   www.baxter.com › baxter-newsroom › baxter-reports

   • Cached

   Feb 4, 2021 · Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended December 31, 2020, and provided its financial guidance for 2021.

7. www.baxterhealthcare.co.uk › sites › gBAXTER REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 RESULTS

   www.baxterhealthcare.co.uk › sites › g

   DEERFIELD, Ill., FEB. 17, 2022 – Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022.

8. People also ask

   How much did Baxter make in 2022?

   • The accompanying schedules include additional details on sales performance by product categories and segments. For full-year 2022, net income (loss) attributable to Baxter totaled ($2.4 billion), or ($4.83) per diluted share on a U.S. GAAP basis.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   Is Baxter International (Bax) a MedTech leader?

   • DEERFIELD, Ill. - 2022-02-17 Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2021, and provided its financial guidance for full-year and first-quarter 2022.

   Baxter Reports Fourth-Quarter and Full-Year 2021 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2021-results

   See all results for this question

   How much did Baxter sell in 2021?

   • Baxter's 2021 worldwide sales totaled $12.8 billion, an increase of 10% on a reported basis, 7% on a constant currency basis and 5% on an operational basis.

   Baxter Reports Fourth-Quarter and Full-Year 2021 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2021-results

   See all results for this question

   What is Baxter's financial outlook for 2023?

   • 2023 Financial Outlook For full-year 2023: Baxter expects sales growth of 1% to 2% on a reported basis and flat to 1% on a constant currency basis. The company expects U.S. GAAP earnings of $1.43 to $1.63 per diluted share and adjusted earnings, before special items, of $2.75 to $2.95 per diluted share.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   What was Baxter's net income in the fourth quarter?

   • For the fourth quarter, net income attributable to Baxter was $181 million, or $0.36 per diluted share, on a U.S. GAAP (Generally Accepted Accounting Principles) basis. These results include special items totaling $263 million after-tax, which were primarily related to intangible amortization, and goodwill and intangible asset impairments.

   Baxter Reports Fourth-Quarter and Full-Year 2022 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2022-results

   See all results for this question

   What is Baxter's fourth-quarter 2021 earnings outlook?

   • The company expects U.S. GAAP earnings of $0.46 to $0.49 per diluted share and adjusted earnings, before special items, of $0.79 to $0.82 per diluted share. A webcast of Baxter's fourth-quarter 2021 conference call for investors can be accessed live from a link on the company’s website at www.baxter.com beginning at 7:30 a.m. CST on Feb. 17, 2022.

   Baxter Reports Fourth-Quarter and Full-Year 2021 Results

   www.baxter.com/baxter-newsroom/baxter-reports-fourth-quarter-and-full-year-2021-results

   See all results for this question

9. finance.yahoo.com › news › baxter-international-incBaxter International Inc (BAX) Surpasses Q1 Earnings and ...

   finance.yahoo.com › news › baxter-international-inc

   • Cached

   May 2, 2024 · Full-year outlook: Adjusted EPS forecast adjusted to $2.88 to $2.98, closely aligning with the annual estimate of $2.90. Segment performance: Pharmaceuticals segment led with an 11% growth,...